Marvel Biosciences Corp
XTSX:MRVL
Marvel Biosciences Corp
XTSX:MRVL
Price:
0.165
CAD
17.86%
Market Closed
Market Cap:
CA$9.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Marvel Biosciences Corp
XTSX:MRVL
|
CA |
|
Kanmonkai Co Ltd
TSE:3372
|
JP |
|
N
|
Nissui Corp
SWB:71N
|
JP |
Income Statement
Earnings Waterfall
Marvel Biosciences Corp
Marvel Biosciences Corp
Income Statement
Marvel Biosciences Corp
Marvel Biosciences Corp
Currency: CAD
| Jan-2022 | Apr-2022 | Jul-2022 | Oct-2022 | Jan-2023 | Apr-2023 | Jul-2023 | Oct-2023 | Jan-2024 | Apr-2024 | Jul-2024 | Oct-2024 | Jan-2025 | Apr-2025 | Jul-2025 | Oct-2025 | Jan-2026 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | ||||||||||||||||||
| Operating Expenses |
(5)
|
(5)
|
(3)
|
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(1)
|
|
| Selling, General & Administrative |
(5)
|
(5)
|
(1)
|
(2)
|
(2)
|
(2)
|
(1)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Research & Development |
0
|
0
|
(1)
|
0
|
0
|
0
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(0)
|
|
| Depreciation & Amortization |
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(5)
N/A
|
(5)
-8%
|
(3)
+50%
|
(2)
+9%
|
(2)
+31%
|
(2)
-19%
|
(2)
-25%
|
(3)
-6%
|
(2)
+4%
|
(2)
+19%
|
(1)
+36%
|
(1)
+16%
|
(1)
-27%
|
(1)
-3%
|
(2)
-11%
|
(2)
-2%
|
(1)
+17%
|
|
| Pre-Tax Income | ||||||||||||||||||
| Interest Income Expense |
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
(1)
|
|
| Pre-Tax Income |
(5)
N/A
|
(5)
-8%
|
(3)
+49%
|
(2)
+8%
|
(2)
+36%
|
(2)
-22%
|
(2)
-25%
|
(3)
-10%
|
(3)
+0%
|
(2)
+16%
|
(2)
+22%
|
(1)
+15%
|
(2)
-18%
|
(2)
+3%
|
(2)
-37%
|
(2)
-3%
|
(2)
+8%
|
|
| Net Income | ||||||||||||||||||
| Income from Continuing Operations |
(5)
|
(5)
|
(3)
|
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
(3)
|
(2)
|
(2)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
|
| Net Income (Common) |
(5)
N/A
|
(5)
-8%
|
(3)
+49%
|
(2)
+8%
|
(2)
+36%
|
(2)
-22%
|
(2)
-25%
|
(3)
-10%
|
(3)
+0%
|
(2)
+16%
|
(2)
+22%
|
(1)
+15%
|
(2)
-18%
|
(2)
+3%
|
(2)
-37%
|
(2)
-3%
|
(2)
+8%
|
|
| EPS (Diluted) |
-0.14
N/A
|
-0.15
-7%
|
-0.08
+47%
|
-0.07
+12%
|
-0.04
+43%
|
-0.05
-25%
|
-0.06
-20%
|
-0.06
N/A
|
-0.06
N/A
|
-0.05
+17%
|
-0.04
+20%
|
-0.03
+25%
|
-0.04
-33%
|
-0.04
N/A
|
-0.05
-25%
|
-0.05
N/A
|
-0.04
+20%
|
|
Switch to:
Switch to:
See Also
Discover More
